Table 2. Cox regression analysis of recurrence-free survival and overall survival (entire cohort).
Univariate
|
Multivariatea
|
|||||
---|---|---|---|---|---|---|
Prognostic factor | HR | (95% CI) | P-value | HR | (95% CI) | P-value |
Recurrence-free survival | ||||||
Cytoplasmic MSX2 (positive vs negative, ref) | 0.489 | 0.285–0.840 | 0.009 | 0.503 | 0.284–0.893 | 0.019 |
T-stage (T2–T4 vs T1, ref) | 7.466 | 2.689–20.739 | <0.001 | 6.372 | 1.955–20.767 | 0.002 |
Ulceration (positive vs negative, ref) | 3.267 | 1.846–5.781 | <0.001 | 2.653 | 1.464–4.809 | 0.001 |
Overall survival | ||||||
Cytoplasmic MSX2 (positive vs negative, ref) | 0.594 | 0.348–1.014 | 0.059 | 0.653 | 0.376–1.136 | 0.132 |
T-stage (T2–T4 vs T1, ref) | 9.696 | 3.021–31.117 | <0.001 | 10.060 | 2.419–41.841 | 0.002 |
Ulceration (positive vs negative, ref) | 3.528 | 2.021–6.160 | <0.001 | 2.900 | 1.610–5.223 | <0.001 |
Abbreviations: CI=confidence interval; HR=hazard ratio; ref=referent group.
Adjusted for all other variables in the subsection. P-values <0.05 are shown in bold.